Jubilant Pharmova Limited (BOM:530019)
1,039.30
-2.35 (-0.23%)
At close: Aug 28, 2025
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
Radiopharma | 33.88B | Log In | Log In | Log In | Log In | Upgrade |
Radiopharma Growth | 12.88% | Log In | Log In | Log In | Log In | Upgrade |
Contract Development and Manufacturing Organisation - Sterile Injectables | 12.72B | Log In | Log In | Log In | Log In | Upgrade |
Contract Development and Manufacturing Organisation - Sterile Injectables Growth | 13.84% | Log In | Log In | Log In | Log In | Upgrade |
Contract Research, and Development and Manufacturing Organisation | 11.51B | Log In | Log In | Log In | Log In | Upgrade |
Contract Research, and Development and Manufacturing Organisation Growth | 5.31% | Log In | Log In | Log In | Log In | Upgrade |
Allergy Immunotherapy | 7.01B | Log In | Log In | Log In | Log In | Upgrade |
Allergy Immunotherapy Growth | 3.35% | Log In | Log In | Log In | Log In | Upgrade |
Generics | 6.85B | Log In | Log In | Log In | Log In | Upgrade |
Generics Growth | -11.53% | Log In | Log In | Log In | Log In | Upgrade |
Management Services | 372.00M | Log In | Log In | Log In | Log In | Upgrade |
Management Services Growth | -2.87% | Log In | Log In | Log In | Log In | Upgrade |
Proprietary Novel Drugs | - | Log In | Log In | Log In | Log In | Upgrade |
Proprietary Novel Drugs Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceuticals | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceuticals Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Contract Research and Development | - | Log In | Log In | Log In | Log In | Upgrade |
Contract Research and Development Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
Americas and Europe | 65.94B | Log In | Log In | Log In | Log In | Upgrade |
Americas and Europe Growth | 9.67% | Log In | Log In | Log In | Log In | Upgrade |
Rest of the World | 4.28B | Log In | Log In | Log In | Log In | Upgrade |
Rest of the World Growth | -14.17% | Log In | Log In | Log In | Log In | Upgrade |
India | 2.13B | Log In | Log In | Log In | Log In | Upgrade |
India Growth | 10.78% | Log In | Log In | Log In | Log In | Upgrade |
China | - | Log In | Log In | Log In | Log In | Upgrade |
China Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Global | - | Log In | Log In | Log In | Log In | Upgrade |